Methods of treating anemia using recombinant adeno-associated virus virions
    3.
    发明申请
    Methods of treating anemia using recombinant adeno-associated virus virions 审中-公开
    使用重组腺相关病毒粒子治疗贫血的方法

    公开(公告)号:US20060099185A1

    公开(公告)日:2006-05-11

    申请号:US11305629

    申请日:2005-12-15

    IPC分类号: A61K48/00

    摘要: The use of recombinant adeno-associated virus (AAV) virions for delivery of DNA molecules to muscle cells and tissue in the treatment of anemia is disclosed, The invention allows for the direct, in vivo injection of recombinant AAV virions into muscle tissue, e.g., by intramuscular injection, as well as for the in vitro transduction of muscle cells which can subsequently be introduced into a subject for treatment. The invention provides for sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery is achieved.

    摘要翻译: 公开了使用重组腺相关病毒(AAV)病毒粒子将DNA分子递送到肌肉细胞和组织以治疗贫血症。本发明允许将重组AAV病毒体直接体内注射入肌肉组织,例如, 通过肌内注射,以及肌肉细胞的体外转导,随后可以将其引入受试者进行治疗。 本发明提供了编码促红细胞生成素的递送核苷酸序列的持续高水平表达,以及用于体内从转导的肌肉细胞分泌,从而实现全身递送。